This inhibition was in a dose-dependent manner in six HCC cell lines (SK-Hep-1, HepG2, Hep3B, Huh-7, PLC/PRF/5, and SMMC-7721) and it was correlated to the level of VEGFR-2 expression. Here, KDR is linked to hepatocellular carcinoma.